The Gastroenterological Association of the United States today released a series of evidence-based statements calling for action for the national cancer control system, which will allow everyone to participate in cancer screening programs (CRC ) without barrier.
CRC experts developed eight statements, which highlight the progress of CRC showingidentify barriers and provide platforms for medical teams, patient consultants, industry, employers, taxpayers and the government to work together to eliminate barriers to assessment.
“CRC measurement saves lives, but only when people are assessed. Cost sharing is an important barrier to assessment, which contributes to racial, ethnic and social inequalities. colorectal cancer the result. The full cost of the show — including non-invasive tests and follow-up of colonoscopy — should be covered at no cost to patients, ”said David Lieberman, MD, AGAF, chairman of the executive committee. AGA on Continuous Display. “The AGA wants to collaborate. With key stakeholders to eliminate barriers to assessment, which has a fair impact on low-income and low-income groups.”
AGA’s description of colorectal cancer reduction:
- The AGA supports the development of a national system to showcase the CRC to ensure access for all people in the United States with the goal of eliminating suffering and death from the CRC.
- There is strong evidence from randomized controlled trials, clinical observational studies, and randomized controlled trials that increasing CRC test value will reduce CRC risk and mortality.
- The screening program should include both colonoscopy and non-invasive screening options, patient education, public awareness, and navigation support.
- Collaborative payments and deductions are barriers to evaluation and contribute to social divisions. Subscribers should cover the full check-in fee without splitting the price.
- Subscribers should cover the screen with high quality colonoscopy without cost sharing, in line with the purpose of the Affordable Care Act. These costs include bowel preparation, equipment and specialist expenses, anesthesia, and pathology.
- Non-invasive color rendering should be considered as a program with several steps, each of which, including subsequent colonoscopy if the test is effective, should be covered by subscribers without sharing price as part of a continuous display.
- The AGA supports further screening to include follow-up of patients diagnosed with high risk of adenomas * (HRA) or advanced sessile serrated lesions (SSLs).
- AGA, working with a large consortium of stakeholders, envisions the provision of natural resources to assist in the management of projects. public health focuses on ensuring effective CRC testing and eliminating barriers to CRC assessment.
The AGA has published these position statements in it Gastroenterology.
David Lieberman et al, Reducing the burden of stomach cancer: AGA Status Statement, Gastroenterology (2022). DOI: 10.1053 / j.gastro.2022.05.011
hintThe AGA has released evidence-based guidelines to guide the creation of a national colorectal cancer screening system (2022, June 14) retrieved 14 June 2022 from https://medicalxpress.com/news/2022-06-aga -evidence-based-principles-creation – kasa.html
This document is copyrighted. Apart from any genuine transaction for the purpose of personal analysis or investigation, any part may not be reproduced without our written permission. Content is provided for informational purposes only.
AGA releases evidence-based principles to guide creation of national colorectal cancer screening approach Source link AGA releases evidence-based principles to guide creation of national colorectal cancer screening approach